Literature DB >> 4414728

Movement and drama therapy with long-stay schizophrenics.

M Nitsun, J H Stapleton, M P Bender.   

Abstract

Mesh：

Year:  1974        PMID： 4414728     DOI： 10.1111/j.2044-8341.1974.tb02275.x

Source DB:  PubMed          Journal:  Br J Med Psychol        ISSN： 0007-1129


× No keyword cloud information.
  6 in total

1.  [Arts therapies in severe mental illness: are they effective?].

Authors:  U Gühne; S Weinmann; K Arnold; E-S Ay; T Becker; S Riedel-Heller
Journal:  Nervenarzt       Date:  2012-07       Impact factor: 1.214

Review 2.  [Psychosocial interventions in severe mental illness: evidence and recommendations: psychoeducation, social skill training and exercise].

Authors:  S G Riedel-Heller; U Gühne; S Weinmann; K Arnold; E-S Ay; T Becker
Journal:  Nervenarzt       Date:  2012-07       Impact factor: 1.214

Review 3.  S3 guideline on psychosocial therapies in severe mental illness: evidence and recommendations.

Authors:  Uta Gühne; Stefan Weinmann; Katrin Arnold; Thomas Becker; Steffi G Riedel-Heller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-11-11       Impact factor: 5.270

4.  A Pilot Remote Drama Therapy Program Using the Co-active Therapeutic Theater Model in People with Serious Mental Illness.

Authors:  Amy Cheung; Victor Agwu; Marko Stojcevski; Laura Wood; Xiaoduo Fan
Journal:  Community Ment Health J       Date:  2022-05-18

5.  Effectiveness of group body psychotherapy for negative symptoms of schizophrenia: multicentre randomised controlled trial.

Authors:  S Priebe; M Savill; T Wykes; R P Bentall; U Reininghaus; C Lauber; S Bremner; S Eldridge; F Röhricht
Journal:  Br J Psychiatry       Date:  2016-05-05       Impact factor: 9.319

6.  Effectiveness and cost-effectiveness of body psychotherapy in the treatment of negative symptoms of schizophrenia--a multi-centre randomised controlled trial.

Authors:  Stefan Priebe; Mark Savill; Ulrich Reininghaus; Til Wykes; Richard Bentall; Christoph Lauber; Paul McCrone; Frank Röhricht; Sandra Eldridge
Journal:  BMC Psychiatry       Date:  2013-01-14       Impact factor: 3.630
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.